PRA Group, a global leader in acquiring and collecting nonperforming loans, has amended and extended its European Credit Agreement, pushing the maturity date from November 2027 to April 2031. The credit facility commitment remains at €730 million with no changes in pricing. This extension supports PRA Group's strategy to strengthen its capital structure and stagger debt maturities, maintaining strong liquidity with no debt maturing until 2028. The company thanked its lending partners for their support as it continues executing its PRA 3.0 strategy.
SpaceX's upcoming IPO may cause forced ETF buying of $22-$27 billion as Nasdaq changes rules to fast-track the company's index inclusion. The Nasdaq 100 now allows new companies to join within 15 days if their market cap ranks in the top 40, removing...
The global Bioprocess Automation Software market, valued at $1.67 billion in 2025, is projected to grow to $6.19 billion by 2035 at a 14% CAGR. This growth is fueled by the increasing demand for personalized medicine, flexible manufacturing processes...
The global microneedle drug delivery systems market is projected to grow from $7.04 billion in 2025 to $14.37 billion by 2035, at a CAGR of 7.4%. Growth is fueled by rising demand for minimally invasive, pain-free, and self-administered drug delivery...
Global Unichip Corp. (GUC) and VSORA introduced Jotunn8, a next-gen AI inference processor designed for datacenter workloads, at the TSMC Europe Technology Symposium. Jotunn8 offers ultra-low latency and high throughput by overcoming memory bottlenec...
Tilray Medical, a global leader in medical cannabis, is participating in Cannabis Europa London 2026, a key forum for discussing medical cannabis regulation and patient access in Europe. The event gathers policymakers, healthcare professionals, and i...
